Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
β-Synuclein (human) (rec.)
Product Details | |
---|---|
Synonyms | SNCB; β-Synuclein |
Product Type | Protein |
Properties | |
Source/Host | E. coli |
Crossreactivity | Human |
Purity | ≥95% (SDS-PAGE) |
Formulation | Lyophilized from PBS pH7.4. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by AbFrontier |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Avoid freeze/thaw cycles. |
Use/Stability | After reconstitution, store at -80°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet |
![]() |
Synuclein is a small, soluble protein primarily expressed in neural tissue. The synuclein family includes three known proteins: α-synuclein, β-synuclein, and γ-synuclein. α-Synuclein is a very conserved, small acidic protein (140 residues) with a molecular weight of approximately 19 kDa that accounts for about 1% of total protein in neurons. It is concentrated primarily in presynaptic axon terminals and plays a central role in initiating Parkinson's disease. It is the principal constituent of Lewy bodies which are formed by protein aggregation and inclusion body formation. α-Synuclein lacks secondary or tertiary structure, so it belongs to the family of natively unfolded proteins, many of which act as chaperones. Much of this α-synuclein has been post-translationally modified to increase the rate of oligomerization. Mutant forms of α-Synuclein are associated with autosomal dominant Parkinson's disease. The mutations increase the aggregation rate of the resultant α-synuclein β-Synuclein is found primarily in brain tissue and is seen mainly in presynaptic terminals. It is predominantly expressed in the neocortex, hippocampus, striatum, thalamus, and cerebellum. β-Synuclein may protect the central nervous system from the neurotoxic effects of α-synuclein by inhibiting aggregation of α-synuclein which occurs in neurodegenerative diseases such as Parkinson's disease. γ-Synuclein is a synuclein protein found primarily in the peripheral nervous system (in primary sensory neurons, sympathetic neurons, and motor neurons) and retina. γ-Synuclein expression in breast tumors is a marker for tumor progression.
1) Irvine GB et al. (2008) Mol Med. 14(7-8):451. (General)
2) Wakabayashi K et al. (2007) Neuropathology. 27(5):494-506. (General)
3) Beyer K. Acta Neuropathol. 112(3):237-251. (General)
4) Bruening W et al. (2000) Cancer. 88(9):2154-2163. (General)